FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to an agent for treating benign prostatic hyperplasia. The antiproliferative agent for treating benign prostatic hyperplasia which contains red deer's antler lipids prepared by extraction of the red deer's antlers in a mixture of the solvents ethanol: ethyl acetate: water in the specific environment.
EFFECT: agent is effective for treating benign prostatic hyperplasia.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIPROLIFERATIVE AGENT | 2012 |
|
RU2482857C1 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
| PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PROSTATE PATHOLOGIES | 2017 |
|
RU2750992C2 |
| 1,2,4-OXADIAZOLE DERIVATIVES OF DESOXYCHOLIC ACID, EXHIBITING PROSTATE-PROTECTIVE EFFECT, HYPOCHOLESTEROLEMIC AND ANTI-INFLAMMATORY ACTIVITY | 2020 |
|
RU2750488C1 |
| MEANS FOR PREVENTION AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2016 |
|
RU2612268C1 |
| REMEDY FOR THE PREVENTION AND TREATMENT OF PROSTATITIS AND BENIGN PROSTATE HYPERPLASIA | 2020 |
|
RU2751342C1 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| MEANS AND METHOD OF CONDITIONS TREATMENT IMPLYING ANDROGEN ACTION DECREASE IS CONSIDERED TO BE FAVOURABLE, AND METHOD OF ANDROGEN-DEPENDENT TISSUE SENSITIVITY ITENSIFYING USING 9-OXOACRIDINE-10-ACETIC ACID | 2006 |
|
RU2328285C2 |
